Drug Resistance, Microbial
"Drug Resistance, Microbial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
| Descriptor ID |
D004352
|
| MeSH Number(s) |
G06.225 G07.690.773.984.269
|
| Concept/Terms |
Drug Resistance, Microbial- Drug Resistance, Microbial
- Drug Resistances, Microbial
- Antimicrobial Drug Resistance
- Antimicrobial Drug Resistances
|
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Microbial".
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Microbial".
This graph shows the total number of publications written about "Drug Resistance, Microbial" by people in this website by year, and whether "Drug Resistance, Microbial" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 3 | 5 |
| 1997 | 0 | 3 | 3 |
| 1999 | 2 | 0 | 2 |
| 2000 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Resistance, Microbial" by people in Profiles.
-
Bayesian modeling of the impact of antibiotic resistance on the efficiency of MRSA decolonization. PLoS Comput Biol. 2023 Oct; 19(10):e1010898.
-
Medications for Treating Infection. JAMA. 2020 01 07; 323(1):100.
-
Pharmacists' perceptions of the effectiveness of antimicrobial control programs. Am J Health Syst Pharm. 2006 Dec 15; 63(24):2504-8.
-
Underestimation of HIV type 1 drug resistance mutations: results from the ENVA-2 genotyping proficiency program. AIDS Res Hum Retroviruses. 2002 Mar 01; 18(4):243-8.
-
Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing. Antimicrob Agents Chemother. 2001 Oct; 45(10):2775-80.
-
Reality check: how should we control antimicrobial use? Current practices and controversies. Infect Control Hosp Epidemiol. 2000 Dec; 21(12):792-5.
-
Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation. 1999 Sep 27; 68(6):814-25.
-
Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories. Antimicrob Agents Chemother. 1999 Jun; 43(6):1500-2.
-
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA. 1999 Feb 10; 281(6):517-23.
-
Vancomycin-resistant enterococci: implications for surgeons. Surgery. 1999 Feb; 125(2):121-5.